z-logo
Premium
Enhanced alveolar fluid clearance following 72 h of continuous isoproterenol infusion in rats
Author(s) -
Pedersen L. R. E.,
Müllertz K. M.,
Amtorp O.,
Christensen S.,
Jonassen T. E. N.
Publication year - 2012
Publication title -
acta physiologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.591
H-Index - 116
eISSN - 1748-1716
pISSN - 1748-1708
DOI - 10.1111/j.1748-1716.2012.02459.x
Subject(s) - amiloride , epithelial sodium channel , chemistry , diltiazem , endocrinology , stimulation , medicine , sodium , calcium , organic chemistry
Aim We wished to determine the effect of continuous β‐receptor stimulation on alveolar fluid clearance and to elucidate the mechanisms behind this effect. Methods Alveolar fluid clearance was measured in anaesthetized rats pretreated for 72 h with the β‐agonist isoproterenol (200 μg kg −1 h −1 sc) or vehicle. Alveolar fluid clearance in artificially ventilated rats was determined over 1 h by infusion of isotonic Ringer solution containing 125 I‐albumin into the lungs. Additionally, alveolar fluid clearance was determined when amiloride or l ‐cis‐diltiazem was added to the solution to block EN aC and cyclic nucleotide‐gated ( CNG ) channels respectively. Results Isoproterenol treatment induced a 42% increase in alveolar fluid clearance (18.9 ± 1.4%) vs. vehicle (13.3 ± 3.3%). Addition of amiloride resulted in a net decrease of 8% in both groups, while l ‐cis‐diltiazem caused a net decrease of 12% in isoproterenol‐treated animals, but only 5% in vehicle‐treated animals. Western blotting showed that isoproterenol treatment increased the abundance of the α‐ EN aC and β‐ EN aC subunits (223 ± 51% and 274 ± 55% of vehicle, respectively) but we saw no changes in protein level of the γ‐EnaC subunit. Conclusion Continuous β‐adrenoceptor stimulation with isoproterenol enhances alveolar fluid clearance through alternative pathways involving l ‐cis‐diltiazem‐sensitive channels.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here